TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC

Yeonhwa Song, Jin Sun Kim, Eun Kyung Choi, Joon Kim, Kang Mo Kim, Haeng Ran Seo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is resistant to conventional chemotherapeutic agents and remains an unmet medical need. Here, we demonstrate a mechanism of cell adhesion-mediated drug resistance using a variety of HCC spheroid models to overcome environment-mediated drug resistance in HCC. We classified spheroids into two groups, tightly compacted and loosely compacted aggregates, based on investigation of dynamics of spheroid formation. Our results show that compactness of HCC spheroids correlated with fibroblast-like characteristics, collagen 1A1 (COL1A1) content, and capacity for chemoresistance. We also showed that ablation of COL1A1 attenuated not only the capacity for compact-spheroid formation, but also chemoresistance. Generally, connective tissue growth factor (CTGF) acts downstream of transforming growth factor (TGF)-β and promotes collagen I fiber deposition in the tumor microenvironment. Importantly, we found that TGF-β-independent CTGF is upregulated and regulates cell adhesion-mediated drug resistance by inducing COL1A1 in tightly compacted HCC spheroids. Furthermore, losartan, which inhibits collagen I synthesis, impaired the compactness of spheroids via disruption of cellcell contacts and increased the efficacy of anticancer therapeutics in HCC cell lineand HCC patient-derived tumor spheroids. These results strongly suggest functional roles for CTGF-induced collagen I expression in formation of compact spheroids and in evading anticancer therapies in HCC, and suggest that losartan, administered in combination with conventional chemotherapy, might be an effective treatment for liver cancer.

Original languageEnglish
Pages (from-to)21650-21662
Number of pages13
JournalOncotarget
Volume8
Issue number13
DOIs
Publication statusPublished - 2017

Fingerprint

Connective Tissue Growth Factor
Transforming Growth Factors
Drug Resistance
Cell Adhesion
Hepatocellular Carcinoma
Collagen
Losartan
Tumor Microenvironment
Liver Neoplasms
Therapeutics
Fibroblasts
Drug Therapy

Keywords

  • Cell adhesion-mediated drug resistance (CAM-DR)
  • Collagen 1A1
  • Connective tissue growth factor (CTGF)
  • Hepatocellular carcinoma
  • Tumor spheroids

ASJC Scopus subject areas

  • Oncology

Cite this

TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC. / Song, Yeonhwa; Kim, Jin Sun; Choi, Eun Kyung; Kim, Joon; Kim, Kang Mo; Seo, Haeng Ran.

In: Oncotarget, Vol. 8, No. 13, 2017, p. 21650-21662.

Research output: Contribution to journalArticle

Song, Yeonhwa ; Kim, Jin Sun ; Choi, Eun Kyung ; Kim, Joon ; Kim, Kang Mo ; Seo, Haeng Ran. / TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC. In: Oncotarget. 2017 ; Vol. 8, No. 13. pp. 21650-21662.
@article{057527d3dea749aab1ab1b0df0133188,
title = "TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC",
abstract = "Hepatocellular carcinoma (HCC) is resistant to conventional chemotherapeutic agents and remains an unmet medical need. Here, we demonstrate a mechanism of cell adhesion-mediated drug resistance using a variety of HCC spheroid models to overcome environment-mediated drug resistance in HCC. We classified spheroids into two groups, tightly compacted and loosely compacted aggregates, based on investigation of dynamics of spheroid formation. Our results show that compactness of HCC spheroids correlated with fibroblast-like characteristics, collagen 1A1 (COL1A1) content, and capacity for chemoresistance. We also showed that ablation of COL1A1 attenuated not only the capacity for compact-spheroid formation, but also chemoresistance. Generally, connective tissue growth factor (CTGF) acts downstream of transforming growth factor (TGF)-β and promotes collagen I fiber deposition in the tumor microenvironment. Importantly, we found that TGF-β-independent CTGF is upregulated and regulates cell adhesion-mediated drug resistance by inducing COL1A1 in tightly compacted HCC spheroids. Furthermore, losartan, which inhibits collagen I synthesis, impaired the compactness of spheroids via disruption of cellcell contacts and increased the efficacy of anticancer therapeutics in HCC cell lineand HCC patient-derived tumor spheroids. These results strongly suggest functional roles for CTGF-induced collagen I expression in formation of compact spheroids and in evading anticancer therapies in HCC, and suggest that losartan, administered in combination with conventional chemotherapy, might be an effective treatment for liver cancer.",
keywords = "Cell adhesion-mediated drug resistance (CAM-DR), Collagen 1A1, Connective tissue growth factor (CTGF), Hepatocellular carcinoma, Tumor spheroids",
author = "Yeonhwa Song and Kim, {Jin Sun} and Choi, {Eun Kyung} and Joon Kim and Kim, {Kang Mo} and Seo, {Haeng Ran}",
year = "2017",
doi = "10.18632/oncotarget.15521",
language = "English",
volume = "8",
pages = "21650--21662",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "13",

}

TY - JOUR

T1 - TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC

AU - Song, Yeonhwa

AU - Kim, Jin Sun

AU - Choi, Eun Kyung

AU - Kim, Joon

AU - Kim, Kang Mo

AU - Seo, Haeng Ran

PY - 2017

Y1 - 2017

N2 - Hepatocellular carcinoma (HCC) is resistant to conventional chemotherapeutic agents and remains an unmet medical need. Here, we demonstrate a mechanism of cell adhesion-mediated drug resistance using a variety of HCC spheroid models to overcome environment-mediated drug resistance in HCC. We classified spheroids into two groups, tightly compacted and loosely compacted aggregates, based on investigation of dynamics of spheroid formation. Our results show that compactness of HCC spheroids correlated with fibroblast-like characteristics, collagen 1A1 (COL1A1) content, and capacity for chemoresistance. We also showed that ablation of COL1A1 attenuated not only the capacity for compact-spheroid formation, but also chemoresistance. Generally, connective tissue growth factor (CTGF) acts downstream of transforming growth factor (TGF)-β and promotes collagen I fiber deposition in the tumor microenvironment. Importantly, we found that TGF-β-independent CTGF is upregulated and regulates cell adhesion-mediated drug resistance by inducing COL1A1 in tightly compacted HCC spheroids. Furthermore, losartan, which inhibits collagen I synthesis, impaired the compactness of spheroids via disruption of cellcell contacts and increased the efficacy of anticancer therapeutics in HCC cell lineand HCC patient-derived tumor spheroids. These results strongly suggest functional roles for CTGF-induced collagen I expression in formation of compact spheroids and in evading anticancer therapies in HCC, and suggest that losartan, administered in combination with conventional chemotherapy, might be an effective treatment for liver cancer.

AB - Hepatocellular carcinoma (HCC) is resistant to conventional chemotherapeutic agents and remains an unmet medical need. Here, we demonstrate a mechanism of cell adhesion-mediated drug resistance using a variety of HCC spheroid models to overcome environment-mediated drug resistance in HCC. We classified spheroids into two groups, tightly compacted and loosely compacted aggregates, based on investigation of dynamics of spheroid formation. Our results show that compactness of HCC spheroids correlated with fibroblast-like characteristics, collagen 1A1 (COL1A1) content, and capacity for chemoresistance. We also showed that ablation of COL1A1 attenuated not only the capacity for compact-spheroid formation, but also chemoresistance. Generally, connective tissue growth factor (CTGF) acts downstream of transforming growth factor (TGF)-β and promotes collagen I fiber deposition in the tumor microenvironment. Importantly, we found that TGF-β-independent CTGF is upregulated and regulates cell adhesion-mediated drug resistance by inducing COL1A1 in tightly compacted HCC spheroids. Furthermore, losartan, which inhibits collagen I synthesis, impaired the compactness of spheroids via disruption of cellcell contacts and increased the efficacy of anticancer therapeutics in HCC cell lineand HCC patient-derived tumor spheroids. These results strongly suggest functional roles for CTGF-induced collagen I expression in formation of compact spheroids and in evading anticancer therapies in HCC, and suggest that losartan, administered in combination with conventional chemotherapy, might be an effective treatment for liver cancer.

KW - Cell adhesion-mediated drug resistance (CAM-DR)

KW - Collagen 1A1

KW - Connective tissue growth factor (CTGF)

KW - Hepatocellular carcinoma

KW - Tumor spheroids

UR - http://www.scopus.com/inward/record.url?scp=85016401260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016401260&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.15521

DO - 10.18632/oncotarget.15521

M3 - Article

AN - SCOPUS:85016401260

VL - 8

SP - 21650

EP - 21662

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 13

ER -